Drugs' influence on blood clotting measured by microfluidic device with artificial arteries
3/27/2014
A new microfluidic method for evaluating drugs commonly used for preventing heart attacks has found that while aspirin can prevent dangerous blood clots in some at-risk patients, it may not be effective in all patients with narrowed arteries.
First framework published for colonoscopy for colorectal cancer screening bundle
3/27/2014
Patients want physicians to provide high-quality care and the health system requires good value for physician work. To help gastroenterologists achieve these goals, the American Gastroenterological Association (AGA) has developed a colonoscopy bundled payment model, which has been published in Gastroenterology 1, the official journal of the AGA.
A deterrent for binge drinking in college students is risk of alcohol-related cancer
3/27/2014
Binge drinking for college students has proven to be a huge problem at many universities. The risk of DUI or even death makes it a public health concern that students and administrators need to face.
Cancer treatments that employ hot nanoparticles
3/27/2014
Nanoparticles have a great deal of potential in medicine: for diagnostics, as a vehicle for active substances or a tool to kill off tumours using heat. ETH Zurich researchers have now developed particles that are relatively easy to produce and have a wide range of applications.If you put your hand over a switched-on torch in the dark, it appears to glow red.
State-of-the-state on genetic-based testing and treatment for breast cancer issued by researchers
3/27/2014
Dartmouth researchers at its Norris Cotton Cancer Center have compiled a review of the role that information gathered through genetic testing plays in the diagnosis and treatment of breast cancer. The paper entitled "Personalized Therapy for Breast Cancer" was accepted for publication in Clinical Genetics.
Faster genetic testing method will likely transform care for many patients with breast cancer
3/27/2014
Faster and cheaper DNA sequencing techniques will likely improve care for patients with breast cancer but also create challenges for clinicians as they counsel patients on their treatment options. Those are among the conclusions of a study published recently in the BJS (British Journal of Surgery). The findings provide insights into how genetic advances will soon be affecting patient care.
Immunotherapy data heralds new era of lung cancer treatment
3/26/2014
A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.
Certain genetic variants may put bladder cancer patients at increased risk of cancer recurrence
3/26/2014
In the Western world, bladder cancer is the fourth most common cancer in men and the eighth most common in women, with many patients experiencing recurrence after treatment. A new study published in BJU International indicates that inheriting certain DNA sequences can affect a patient's prognosis.
Weill Cornell scientists find gene implicated in progression and relapse of deadly breast cancer
3/26/2014
Scientists from Weill Cornell Medical College and Houston Methodist have found that a gene previously unassociated with breast cancer plays a pivotal role in the growth and progression of the triple negative form of the disease, a particularly deadly strain that often has few treatment options.
New enhanced microbial killing discovered in neutrophils
3/26/2014
Case Western Reserve University researchers have discovered a novel population of neutrophils, which are the body's infection control workhorses. These cells have an enhanced microbial killing ability and are thereby better able to control infection.